The steroid sulfatase (STS) plays a major role in the regulation of steroid hormone concentrations in several human tissues and target organs and therefore, represents an interesting target to regulate estrogen and androgen levels implicated in different diseases. In this review article, the emphasis is put on STS inhibitors reported in the fruitful 2000-2010 decade, which consolidated the first ones that were previously developed (1990-1999). The inhibitors reviewed are divided into four categories according to the fact that they are sulfamoylated or not or that they have a steroid nucleus or not. Other topics such as function, localization, structure and mechanism as well as applications of STS inhibitors are also briefly discussed to complement the information on this crucial steroidogenic enzyme and its inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.steroids.2011.03.010DOI Listing

Publication Analysis

Top Keywords

steroid sulfatase
8
2000-2010 decade
8
sts inhibitors
8
inhibitors
5
steroid
4
sulfatase inhibitors
4
inhibitors review
4
review covering
4
covering promising
4
promising 2000-2010
4

Similar Publications

Steroid sulfatase suppresses keratinization by inducing proteasomal degradation of E-cadherin via Hakai regulation.

Biochim Biophys Acta Mol Cell Res

January 2025

College of Pharmacy and Center for Metareceptome Research, Chung-Ang University, Seoul 06974, Republic of Korea. Electronic address:

X-linked ichthyosis (XLI) is a genetic disorder characterized by a steroid sulfatase (STS) deficiency inducing excessive cholesterol sulfate accumulation and keratinization. Our study utilizes STS knockout mice to reproduce the hyperkeratinization typical of XLI, providing a valuable model for investigating the underlying mechanisms. From the experiment of STS-deficient keratinocytes using the CRISPR/Cas9 system, we observed upregulation of E-cadherin, which is associated with keratinocyte differentiation and stratification.

View Article and Find Full Text PDF

Enhanced expression of Cyp17a1 and production of DHEA-S in the liver of late-pregnant rats.

Gen Comp Endocrinol

January 2025

Laboratory of Veterinary Biochemistry, Department of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan.

Cytochrome P450 17A1 (CYP17A1) catalyzes two enzymatic reactions in the biosynthesis of dehydroepiandrosterone (DHEA) from pregnenolone. In pregnant humans, the adrenal gland is responsible for DHEA biosynthesis, which is then sulfated by SULT2A1 and released into the bloodstream. This sulfated DHEA is subsequently taken up by the placenta and deconjugated to serve as a precursor for estrogen biosynthesis.

View Article and Find Full Text PDF

Background/aim: Breast cancer is mostly affected by estrogen, which promotes proliferation, tumorigenesis, and cancer progression. Estrogen sulfotransferase (SULT1E1) catalyzes sulfation to inactivate estrogens, whereas steroid sulfatase (STS) catalyzes estrogen sulfate hydrolysis to activate estrogens in breast cancer cells. Three major organosulfur compounds in garlic (Allium sativum L.

View Article and Find Full Text PDF

The diagnostic prevalence of autism spectrum disorders (ASD) shows boys to be more affected than girls. Due to this reason, there is a lack of research including and observing ASD girls. Present study was aimed to detect hormones of steroidogenesis pathway in prepubertal girls (n = 16) diagnosed with ASD and sex and age matched neurotypical controls (CTRL, n = 16).

View Article and Find Full Text PDF

Recent advances in the development of 17beta-hydroxysteroid dehydrogenase inhibitors.

Steroids

January 2025

Laboratory of Medicinal Chemistry, Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada.

Article Synopsis
  • The 17β-hydroxysteroid dehydrogenases (17β-HSDs) family has multiple isoforms that can convert steroids between their alcohol and carbonyl forms based on the cofactor available.
  • These enzymes play crucial roles in regulating estrogens and androgens, making them promising targets for therapies against conditions like breast cancer, prostate cancer, and Alzheimer's disease.
  • The article reviews recent developments in inhibitors targeting various isoforms, highlighting both traditional and new dual inhibitors, organized by type and research group for clarity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!